Nā ʻōkuhi no ka hoʻohana ʻana iā Glidiab MV > He hoʻomaʻemaʻe a me ke pale aku

ʻO ka lāʻau lapaʻau no ka maʻi maʻi ʻole wale nō ka hoʻololi ʻana i ka meaʻai, akā i ka hoʻohana ʻana i nā lāʻau lapaʻau kūikawā.

Me ka maʻi type 2, maʻamau nā kānaka i nā lāʻau lapaʻau e hoʻokō ai i ka glycemia maʻamau. ʻO kekahi lāʻau lapaʻau ʻo Glidiab MV.

ʻO ka ʻike nui, ka hoʻonohonoho ʻana a me ke ʻano o ka hoʻokuʻu ʻana

ʻO ka lāʻau lapaʻau ʻO Glidiab MV kekahi o nā derivatives o ka sulfonylurea (2 mau hanauna), no laila ke manaʻo nei e hoʻowalewale i nā cell beta i loaʻa i ka pancreas.

ʻO ka lāʻau lapaʻau i hana ʻia ma ka wahi i Moscow e ka hui lāʻau lapaʻau ʻo Akrikhin a ua manaʻo ʻia he analogue o nā papa hypoglycemic Diabeton MV, i hana ʻia ma Farani. Loaʻa i ka ʻohu he palapala kaukaʻi ʻia e ka mea hoʻohemo ʻia.

Loaʻa ka lāʻau lapaʻau i ke ʻano o nā papa i loaʻa nā tint a keʻokeʻo. Hoʻohālikelike lākou i ke ʻano o nā cylinders flat. Loaʻa ka lāʻau lapaʻau i nā paʻi o 30 a 60 mau papa.

Hoʻohālikelike me ka MV Diabeton, nona kahi 0,06 g, aia ʻo Glidiab MV i ka hapalua o ka hana ikaika (0,03 g).

ʻO Gliclazide ka mea nui,
cellulose (microcrystalline),
hydroxypropyl methylcellulose,
konekena stearate,
Aerosil

Ua kuhikuhi ʻia nā poʻe maʻi he nui ʻo Glidiab 80, kahi e loaʻa ai ka hana ikaika, ʻaʻohe 30 mg, akā he 80 mg ma kēlā me kēia papa.

Ka hana lāʻau lapaʻau

Hoʻopilikia ka māhele o Glidiab MV i ke kino penei:

e hoʻolōʻihi i ka ʻili o ka insulin i hana ʻia ma ka pancreas,
hoʻonui i ka naʻau maʻi i ka hormone i hana ʻia,
hoʻemi i ka waʻa mai ka manawa o ka ʻai meaʻai e hoʻokuʻu i ka hoʻokuʻu ʻana i ka insulin,
ma lalo o ka hopena o kēia lāʻau lapaʻau, hoʻihoʻi ʻia ka hoʻohuihui insulin i ka wā mua i hoʻohālikelike ʻia i nā mea ola ʻē aʻe o ka olalona.
hoʻomaikaʻi i ka microcirculation ma muli o ka plelethes adhesion, hoʻihoʻi i ka hoʻoneʻe pālua vascular a me ka hoʻohaʻahaʻa haʻahaʻa o ka microthrombosis,
hoʻemi i ka glycemia,
kōkua kōkua hoopau i ka protenuria,
e hoʻolohi i ka hoʻomohala ʻana o ka retinopathy,
komo i ka hoʻohaʻahaʻa ʻana, kau ʻia i ka papa kauoha.

Lapaʻau lāʻau

ʻO ke kaʻina o ka hue ʻana, ka hoʻohele ʻia i loko o ke kino, ka hana metabolism a me ka hoʻopā ʻana o nā mea i kū like penei:

Kapehu. ^ E Ha yM. Ua aneane piha ʻia ka lāʻau lapaʻau ma o ka digestive tract (gastrointestinal tract). Piʻi ʻia kona kukuna i ka plasma, a hiki i kona lōʻihi loa mai ke manawa o ka hoʻokele ʻana ma hope o 6 a 12 paha hola. ʻAʻole pili ʻia nā laka i ka nui o ke kahe mau ʻana. Pono ka lāʻau no 24 mau hola.
Kahele. ^ E Ha yM. Ke hoʻonohonoho nei me nā protein plasma a me nā ʻāpana lāʻau i hoʻonoho ʻia ma 95%.
Hāpai. ^ E Ha yM. Hana ʻia kēia hana i ka puʻuwai, i hiʻohiʻona ʻia e ka hoʻokumu ʻana o nā metabolites kūpono ʻole.
Leʻaleʻa. ^ E Ha yM. Ke hele nei ka hana ma waena o nā keiki i ke ʻano o ka metabolites, ʻo ka mea 1 wale nō o ka lāka e puka mai me ka urine. ʻO ka hoʻopauʻana hapa hapalua-ola o ka lāʻau lapaʻau e loaʻa ana i 16 mau hola.

ʻAʻole loli e nā kaʻina lāʻau pharmacokinetic o nā lāʻau lapaʻau i nā maʻi maʻi kahiko.

Nā hōʻailona a me nā contraindications

ʻO nā papa Glidiab MV he hypoglycemic nā lāʻau lapaʻau, no laila, ua hoʻohana ʻia i ka hoʻōla ʻana o ka maʻi type 2, i nā ala ʻē aʻe o ka hoʻohaʻahaʻa i ka glucose i hoʻihoʻi ʻole i ka hōʻailona.

ʻO nā kumumanaʻo ka lawe ʻana i ka lāʻau lapaʻau nā:

ketoacidosis
hana koʻikoʻi nā keiki,
ʻAno maʻi type 1
coma (maʻi maʻi maʻi a i ʻole hyperosmolar),
hana
nā hōʻeha
ke alohele ʻia,
hapai
Nā kūlana e kū ai ka hypoglycemia (no ka laʻana, nā maʻi o kahi ʻano maʻi)
leukopenia
pālahalā nui
hypersensitivity o nā mea i loko o ka hana o ka huahana,
hana waiū.

Nā ʻōkuhi no ka hoʻohana a me nā ʻōlelo aʻoaʻo kūikawā

ʻO ka make ʻana o ka lāʻau lapaʻau e hilinaʻi ʻia i nā hiʻohiʻona o ke ʻano o ka maʻi maʻi a me nā hōʻike, no laila ua koho ʻia e ke kauka ponoʻī no kēlā me kēia maʻi.

I ka hoʻomaka ʻana o ka lawe ʻana i ka lāʻau lapaʻau, kahi pāʻālua o 30 mg a i ʻole 1 papa e kuhikuhi ʻia. Aia i ke kūlana o ka mea maʻi i ka wā o ka hōʻola, hiki ke hoʻonui ʻia i ka nui o ka waiwai ikaika i kēlā me kēia lā i 120 mg (nui loa).

Lawe ʻia nā papa papaʻaila i ka wā pāʻina (hoʻokahi lā i kahi lā). Hōʻalo ʻia kahi hoʻomaʻamaʻa haʻahaʻa (me ka mea hana mai 15 a 80 ml / min) ʻaʻole ia e hoʻoponopono ʻia.

I ka hoʻomaka ʻana o nā lāʻau lapaʻau a hiki i ke koho ʻana i ka ʻai kūpono pono, ʻike pinepine nā mea maʻi i ka hypoglycemia e hana i ka hana e koi ana i ka pane wikiwiki a i ʻole ka hoʻonui nui ʻana.

ʻAʻole pono nā wahine e hoʻohana i ka lāʻau lapaʻau i ka wā o ka hānau ʻana i kahi keiki, ʻo ia hoʻi e ʻoki.

ʻO kahi hōʻeha koʻikoʻi o ka hanaʻino i ka pūpū a me nā palaka paha e pāpā i ka hoʻohana ʻana i ka lāʻau lapaʻau a hiki i nā mea liʻiliʻi loa.

He mea makemake no ka hoʻokō ʻana i ka hopena o ka noi ke hahai ʻana i kahi meaʻaiʻai a me ka hana maʻalahi. I nā meaʻai maʻamau i kēlā me kēia lā, pono nā mea momona i loko o kahi liʻiliʻi.
He mea pono ia e nānā ʻia ka glycemia ma mua a ma hope o ka ʻaina a hiki ke hoʻoponopono ʻia ke kūpaʻa e pili ana i nā hualoaʻa.
No ka hana ʻana, a i ʻole ke decompensated diabetes, pono e pono ke loli i ka lāʻau me nā inikini insulin.
I mea e pale ai i ka loaʻa ʻana o ka hypoglycemia, me kahi hopena like ʻole disulfiram, ʻaʻole inu i ka wai inu.
Lā ʻae ʻia ke kaʻai ʻana i nā meaʻai, ke nānā ʻole i nā mea ʻai i ka manawa o ka pōloli.
Ma mua o ka hoʻoikaika kino paʻakikī, pono e hōʻemi ʻia ka ʻona.

ʻO ka mea pili pono i ka lāʻau hypoglycemic i:

poʻe i nā makahiki kahiko
nā mea maʻi e hiki ʻole ke ʻai i ka ʻai,
poʻe me ka ʻiʻo nāwaliwali
nā mea maʻi me ka maʻi e like me ka lawa o ka pituitary-adrenal.

Nā hopena ʻaoʻao a me ka overdose

Hiki i nā kīhāpai ke hōʻake i kēia mau hopena ma kahi kanaka:

e pili ana i ka pūnaehana endocrine - hypoglycemia me ke ʻano o ka manaʻo o ke poʻo, ka ʻōpū, ka nāwaliwali, ke kaumaha nei, nā kīʻaha, nā haʻalulu, ka nalowale o ka ʻike, ʻike maka ʻole a me ka hoʻonohonoho ʻana o ka neʻe,
mai ka ʻaoʻao o ka hāwili ʻana - ka dyspepsia, anorexia, nā pilikia hoʻi o ka ate,
leukopenia, thrombocytopenia, anemia,
kahi hōʻike kūloko (hāhai, ʻeha, a i ʻole urticaria).

Me kahi overdose o ka lāʻau, loaʻa ka hypoglycemia. No ka hoʻopau ʻana i kāna mau ʻōuli, lawa ia e hoʻopau i kekahi mau palaka, i ʻike ʻia e ʻike ke kanaka. I nā kūlana i hiki ʻole i ka mea maʻi ke ʻai i ka ʻai, pono kāna e hāʻawi ʻia i kahi momona glucose intravenous (40%) a i kahi intramuscular injox. Ma hope o ka hoʻi ʻana i ka maʻi me kahi maʻi maʻi, pono ʻoe e loaʻa kahi aʻa e pale ai i kahi hāʻule pinepine i ka glucose.

Hoʻopili pū kekahi me nā lāʻau lapaʻau a me nā hōʻailona

ʻO ka hoʻohana ʻana i nā lāʻau lapaʻau ʻē aʻe e hui pū me Glidiab MV e hoʻomaikaʻi a hoʻoemi paha i ka hopena hypoglycemic.

Hoʻohui hui ʻia me nā lāʻau lapaʻau e like me:

E hoʻoneʻe ana ʻo ACE,
antifungal āpana (fluconazole),
Nā NSAID
antihistamines
Hoʻopuka ʻana
lāʻau lapaʻau anti-tuberkulosis
Kahiko,
Pentoxifylline
Ethanol
nā mea kanu e pāpā ai i ka ʻili huna tubular.

Hoʻomaʻamaʻa ʻia ka hopena hypoglycemic i ka wā i hui pū ʻia me nā lāʻau lapaʻau penei:

pani ʻia
nauwe
Puʻu
nā maʻi e hoʻomau i ka hana thyroid,
Hoʻomākaukau lithium
estrogens
ʻo ke ʻano o ka ʻōpū o ka waha.

I waena o nā lāʻau lapaʻau e loaʻa ai ka hopena e like me nā papa Glidiab MV, ʻoi aku ka ʻōlelo maʻamau:

Meglimide
Alarahi
Hoʻololi,
Clay,
Glimepiride
Hoʻopau
Glairy
Kelepaea,
Kuiluna.

Mea pono wikiō e pili ana i ka maʻi maʻi, kona ʻano a me kā ka hoʻopaʻa ʻana:

ʻO ka manaʻo o nā mea maʻi a me nā kauka

Mai nā loiloi hoʻomanawanui, hiki iā mākou ke hoʻopau i ka lāʻau maikaʻi ʻana me ka hoʻokō pono. Eia naʻe, koi wale nā kauka i ka hoʻohana ʻana i ka lāʻau ma hope o ka nīnau ʻana i kahi loea.

ʻO ka hopena maikaʻi loa. E kū'ē i ke kua o ke koʻikoʻi koʻikoʻi, loaʻa iaʻu kahi kokoke i 30 kg, ʻoiai inā ʻaʻole wau i hoʻololi i kaʻu papaʻai. I ka hopena, ua loaʻa iaʻu ke kō koko kiʻekiʻe. Kauoha mai ke kauka e lawe i nā papa he 2 o ka Glidiab MV i kēlā me kēia kakahiaka, a i ke ahiahi e inu i ka 1 papa o Glucofage 1000. Mahalo i kēia hoʻoponopono ʻana, ua hāʻule ka ʻōmaʻomaʻo glucose e nā ʻāpana he 4 a hoʻomau ka noho mau ma kahi o 7 mmol / L mau.

Kristina, hoʻomanawanui, 47 makahiki

Maʻalahi ka lāʻau lāʻau e hoʻohana ai. He nui nā contraindications o Glidiab CF, no laila, ʻaʻole pono nā poʻe maʻi e hoʻomaka e lawe iā lākou iho ma ka ʻole o ka ʻae ʻana mai ke kauka i hele mai. Pono e kiaʻi pinepine i ka glycemia a hoʻopaʻa i ka pono o ka lāʻau lapaʻau lāʻau me ka endocrinologist. Me kahi regimen lapaʻau i koho ʻia, hiki iā ia ke hoʻololi iki i ka hōʻailona glucose. Hoʻololi ʻia ka lāʻau lapaʻau i loko o nā lāʻau lapaʻau me kahi laina, akā loaʻa i nā poʻe i hōʻeha ʻia mai kēia maʻi me ka manuahi, ʻo ia mau ke kiaʻi mau ʻana e nā poʻe loea o kā lākou lāʻau lapaʻau.

ʻO Victor Vladimirovich, ke kauka

ʻO ke kumu kūʻai o 60 mau papa o Glidiab MV i kahi pahu e pili ana iā 200 mau rubles.